1. Home
  2. BWFG vs MOLN Comparison

BWFG vs MOLN Comparison

Compare BWFG & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWFG
  • MOLN
  • Stock Information
  • Founded
  • BWFG 2002
  • MOLN 2004
  • Country
  • BWFG United States
  • MOLN Switzerland
  • Employees
  • BWFG N/A
  • MOLN N/A
  • Industry
  • BWFG Major Banks
  • MOLN
  • Sector
  • BWFG Finance
  • MOLN
  • Exchange
  • BWFG Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • BWFG 223.3M
  • MOLN 218.1M
  • IPO Year
  • BWFG N/A
  • MOLN 2021
  • Fundamental
  • Price
  • BWFG $32.25
  • MOLN $5.31
  • Analyst Decision
  • BWFG Buy
  • MOLN Hold
  • Analyst Count
  • BWFG 1
  • MOLN 1
  • Target Price
  • BWFG $34.00
  • MOLN $4.50
  • AVG Volume (30 Days)
  • BWFG 16.1K
  • MOLN 40.7K
  • Earning Date
  • BWFG 10-28-2024
  • MOLN 08-26-2024
  • Dividend Yield
  • BWFG 2.48%
  • MOLN N/A
  • EPS Growth
  • BWFG N/A
  • MOLN N/A
  • EPS
  • BWFG 1.94
  • MOLN N/A
  • Revenue
  • BWFG $72,009,000.00
  • MOLN $7,105,397.00
  • Revenue This Year
  • BWFG N/A
  • MOLN N/A
  • Revenue Next Year
  • BWFG $9.07
  • MOLN $29.41
  • P/E Ratio
  • BWFG $16.59
  • MOLN N/A
  • Revenue Growth
  • BWFG N/A
  • MOLN N/A
  • 52 Week Low
  • BWFG $22.47
  • MOLN $3.32
  • 52 Week High
  • BWFG $33.17
  • MOLN $12.70
  • Technical
  • Relative Strength Index (RSI)
  • BWFG 62.39
  • MOLN 45.05
  • Support Level
  • BWFG $30.73
  • MOLN $5.67
  • Resistance Level
  • BWFG $32.39
  • MOLN $6.24
  • Average True Range (ATR)
  • BWFG 0.78
  • MOLN 0.37
  • MACD
  • BWFG 0.36
  • MOLN -0.11
  • Stochastic Oscillator
  • BWFG 81.85
  • MOLN 12.58

About BWFG Bankwell Financial Group Inc.

Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses, and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: